Pirh2 E3 ubiquitin ligase modulates keratinocyte differentiation through p63

Journal of Investigative Dermatology

Volumn 133, Issue 5, 2013, Pages 1178-1187

  Jung, Yong Sam ^a   Qian, Yingjuan ^a   Yan, Wensheng ^a   Chen, Xinbin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PIRH2 E3 UBIQUITIN LIGASE; PROTEIN P63; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; ENZYME ACTIVITY; KERATINOCYTE; POLYUBIQUITINATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PROCESSING; PROTEIN TARGETING; UBIQUITINATION;

EID: 84876679235     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.466     Document Type: Article

References (72)

1. Balint E, Bates S, Vousden KH (1999) Mdm2 binds p73 alpha without targeting degradation. Oncogene 18:3923-9
2. Brooks CL, Gu W (2006) p53 ubiquitination: Mdm2 and beyond. Mol Cell 21:307-15
3. Calabro V, Mansueto G, Parisi T et al. (2002) The human MDM2 oncoprotein increases the transcriptional activity and the protein level of the p53 homolog p63. J Biol Chem 277:2674-81
4. Candi E, Dinsdale D, Rufini A et al. (2007) TAp63 and DeltaNp63 in cancer and epidermal development. Cell Cycle 6:274-85
5. Candi E, Schmidt R, Melino G (2005) The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 6:328-40
6. Chikh A, Sayan E, Thibaut S et al. (2007) Expression of GATA-3 in epidermis and hair follicle: relationship to p63. Biochem Biophys Res Commun 361:1-6
7. Chowdary DR, Dermody JJ, Jha KK et al. (1994) Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway. Mol Cell Biol 14:1997-2003
8. Cui R, Widlund HR, Feige E et al. (2007) Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell 128:853-64
9. Deyrieux AF, Wilson VG (2007) In vitro culture conditions to study keratino-cyte differentiation using the HaCaT cell line. Cytotechnology 54:77-83
10. Di Costanzo A, Festa L, Duverger O et al. (2009) Homeodomain protein Dlx3 induces phosphorylation-dependent p63 degradation. Cell Cycle 8:1185-95
11. Dohn M, Zhang S, Chen X (2001) p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes. Oncogene 20:3193-205
12. Duan S, Yao Z, Hou D et al. (2007) Phosphorylation of Pirh2 by calmodulin-dependent kinase II impairs its ability to ubiquitinate p53. EMBO J 26:3062-74
13. Duan S, Yao Z, Zhu Y et al. (2009) The Pirh2-keratin 8/18 interaction modulates the cellular distribution of mitochondria and UV-induced apoptosis. Cell Death Differ 16:826-37
14. Duan W, Gao L, Druhan LJ et al. (2004) Expression of Pirh2, a newly identified ubiquitin protein ligase, in lung cancer. J Natl Cancer Inst 96:1718-21
15. Duan W, Gao L, Wu X et al. (2006) Differential response between the p53 ubiquitin-protein ligases Pirh2 and MdM2 following DNA damage in human cancer cells. Exp Cell Res 312:3370-8
16. Flores ER, Sengupta S, Miller JB et al. (2005) Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family. Cancer Cell 7:363-73
17. Gaiddon C, Lokshin M, Ahn J et al. (2001) A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain. Mol Cell Biol 21:1874-87
18. Gallegos JR, Litersky J, Lee H et al. (2008) SCF TrCP1 activates and ubiquitylates TAp63gamma. J Biol Chem 283:66-75
19. Galli F, Rossi M, D'Alessandra Y et al. (2010) MDM2 and Fbw7 cooperate to induce p63 protein degradation following DNA damage and cell differentiation. J Cell Sci 123:2423-33
20. Guo X, Keyes WM, Papazoglu C et al. (2009) TAp63 induces senescence and suppresses tumorigenesis in vivo. Nat Cell Biol 11:1451-7
21. Hagiwara K, McMenamin MG, Miura K et al. (1999) Mutational analysis of the p63/p73L/p51/p40/CUSP/KET gene in human cancer cell lines using intronic primers. Cancer Res 59:4165-9
22. Hakem A, Bohgaki M, Lemmers B et al. (2011) Role of Pirh2 in mediating the regulation of p53 and c-Myc. PLoS Genet 7:e1002360
23. Helton ES, Zhu J, Chen X (2006) The unique NH2-terminally deleted (DeltaN) residues, the PXXP motif, and the PPXY motif are required for the transcriptional activity of the DeltaN variant of p63. J Biol Chem 281:2533-42
24. Hibi K, Trink B, Patturajan M et al. (2000) AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci USA 97:5462-7
25. Joerger AC, Rajagopalan S, Natan E et al. (2009) Structural evolution of p53, p63, and p73: implication for heterotetramer formation. Proc Natl Acad Sci USA 106:17705-10
26. Jung YS, Hakem A, Hakem R et al. (2011a) Pirh2 E3 ubiquitin ligase monoubiquitinates DNA polymerase eta to suppress translesion DNA synthesis. Mol Cell Biol 31:3997-4006
27. Jung YS, Kim HY, Kim J et al. (2008) Physical interactions and functional coupling between Daxx and sodium hydrogen exchanger 1 in ischemic cell death. J Biol Chem 283:1018-25
28. Jung YS, Liu G, Chen X (2010) Pirh2 E3 ubiquitin ligase targets DNA polymerase eta for 20S proteasomal degradation. Mol Cell Biol 30:1041-8
29. Jung YS, Qian Y, Chen X (2011b) The p73 tumor suppressor is targeted by Pirh2 RING finger E3 ubiquitin ligase for the proteasome-dependent degradation. J Biol Chem 286:35388-95
30. Jung YS, Qian Y, Chen X (2012) Pirh2 RING-finger E3 ubiquitin ligase: its role in tumorigenesis and cancer therapy. FEBS Lett 586:1397-402
31. King KE, Ponnamperuma RM, Yamashita T et al. (2003) deltaNp63alpha functions as both a positive and a negative transcriptional regulator and blocks in vitro differentiation of murine keratinocytes. Oncogene 22:3635-44
32. Kommagani R, Caserta TM, Kadakia MP (2006) Identification of vitamin D receptor as a target of p63. Oncogene 25:3745-51
33. Koster MI, Kim S, Mills AA et al. (2004) p63 is the molecular switch for initiation of an epithelial stratification program. Genes Dev 18:126-31
34. Koster MI, Roop DR (2004) The role of p63 in development and differentiation of the epidermis. J Dermatol Sci 34:3-9
35. Laurikkala J, Mikkola ML, James M et al. (2006) p63 regulates multiple signalling pathways required for ectodermal organogenesis and differentiation. Development 133:1553-63
36. Lee H, Kimelman D (2002) A dominant-negative form of p63 is required for epidermal proliferation in zebrafish. Dev Cell 2:607-16
37. Lee JT, Gu W (2010) The multiple levels of regulation by p53 ubiquitination. Cell Death Differ 17:86-92
38. Leng RP, Lin Y, Ma W et al. (2003) Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell 112:779-91
39. Li Y, Peart MJ, Prives C (2009) Stxbp4 regulates DeltaNp63 stability by suppression of RACK1-dependent degradation. Mol Cell Biol 29:3953-63
40. Li Y, Zhou Z, Chen C (2008) WW domain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin-mediated proteaso-mal degradation and regulates apoptosis. Cell Death Differ 15:1941-51
41. Mangiulli M, Valletti A, Caratozzolo MF et al. (2009) Identification and functional characterization of two new transcriptional variants of the human p63 gene. Nucleic Acids Res 37:6092-104
42. Maya R, Balass M, Kim ST et al. (2001) ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes Dev 15:1067-77
43. McKeon F (2004) p63 and the epithelial stem cell: more than status quo? Genes Dev 18:465-9
44. Melino G, De Laurenzi V, Vousden KH (2002) p73: Friend or foe in tumorigenesis. Nat Rev Cancer 2:605-15
45. Mills AA, Zheng B, Wang XJ et al. (1999) p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398:708-13
46. Miyazaki K, Ozaki T, Kato C et al. (2003) A novel HECT-type E3 ubiquitin ligase, NEDL2, stabilizes p73 and enhances its transcriptional activity. Biochem Biophys Res Commun 308:106-13
47. Ohkumo T, Kondo Y, Yokoi M et al. (2006) UV-B radiation induces epithelial tumors in mice lacking DNA polymerase eta and mesenchymal tumors in mice deficient for DNA polymerase iota. Mol Cell Biol 26:7696-706
48. Ongkeko WM, Wang XQ, Siu WY et al. (1999) MDM2 and MDMX bind and stabilize the p53-related protein p73. Curr Biol 9:829-32
49. Peschiaroli A, Scialpi F, Bernassola F et al. (2009) The F-box protein FBXO45 promotes the proteasome-dependent degradation of p73. Oncogene 28:3157-66
50. Pillai S, Bikle DD (1992) Lanthanum influx into cultured human keratino-cytes: effect on calcium flux and terminal differentiation. J Cell Physiol 151:623-9
51. Ponting CP (1995) SAM: a novel motif in yeast sterile and Drosophila polyhomeotic proteins. Protein Sci 4:1928-30
52. Prives C, Hall PA (1999) The p53 pathway. J Pathol 187:112-26
53. Qian Y, Jung YS, Chen X (2011) DeltaNp63, a target of DEC1 and histone deacetylase 2, modulates the efficacy of histone deacetylase inhibitors in growth suppression and keratinocyte differentiation. J Biol Chem 286:12033-41
54. Rocco JW, Leong CO, Kuperwasser N et al. (2006) p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. Cancer Cell 9:45-56
55. Rock KL, Gramm C, Rothstein L et al. (1994) Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78:761-71
56. Rossi M, Aqeilan RI, Neale M et al. (2006) The E3 ubiquitin ligase Itch controls the protein stability of p63. Proc Natl Acad Sci USA 103:12753-8
57. Rossi M, De Laurenzi V, Munarriz E et al. (2005) The ubiquitin-protein ligase Itch regulates p73 stability. Embo J 24:836-48
58. Senoo M, Pinto F, Crum CP et al. (2007) p63 Is essential for the proliferative potential of stem cells in stratified epithelia. Cell 129:523-36
59. Shieh SY, Ikeda M, Taya Y et al. (1997) DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91:325-34
60. Su X, Cho MS, Gi YJ et al. (2009a) Rescue of key features of the p63-null epithelial phenotype by inactivation of Ink4a and Arf. EMBO J 28: 1904-15
61. Su X, Paris M, Gi YJ et al. (2009b) TAp63 prevents premature aging by promoting adult stem cell maintenance. Cell Stem Cell 5:64-75
62. Truong AB, Kretz M, Ridky TW et al. (2006) p63 regulates proliferation and differentiation of developmentally mature keratinocytes. Genes Dev 20:3185-97
63. Wang X, Arooz T, Siu WY et al. (2001) MDM2 and MDMX can interact differently with ARF and members of the p53 family. FEBS Lett 490:202-8
64. Watt FM (1983) Involucrin and other markers of keratinocyte terminal differentiation. J Invest Dermatol 81:100s-3s
65. Wu G, Nomoto S, Hoque MO et al. (2003) DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development. Cancer Res 63:2351-7
66. Wu H, Zeinab RA, Flores ER et al. (2011) Pirh2, a ubiquitin E3 ligase, inhibits p73 transcriptional activity by promoting its ubiquitination. Mol Cancer Res 9:1780-90
67. Wu X, Bayle JH, Olson D et al. (1993) The p53-mdm-2 autoregulatory feedback loop. Genes Dev 7:1126-32
68. Yang A, Kaghad M, Caput D et al. (2002) On the shoulders of giants: p63, p73 and the rise of p53. Trends Genet 18:90-5
69. Yang A, Kaghad M, Wang Y et al. (1998) p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2:305-16
70. Yang A, McKeon F (2000) P63 and P73: P53 mimics, menaces and more. Nat Rev Mol Cell Biol 1:199-207
71. Yang A, Schweitzer R, Sun D et al. (1999) p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398:714-8
72. Zhang J, Jun Cho S, Chen X (2010) RNPC1, an RNA-binding protein and a target of the p53 family, regulates p63 expression through mRNA stability. Proc Natl Acad Sci USA 107:9614-9